ASX
LCT 0.115   Last updated 5.25 am
Fact sheet
The following fact sheets provide a summary of our current business and research pipeline.
Register for email updates
Register now to receive our newsletter and updates on LCT’s activities and progress.

Fact sheet

The following fact sheet provides a summary of our current business and research pipeline.

Technology platforms

Our breakthrough encapsulation delivery technology, IMMUPEL™, enables treatments to be delivered without immunosuppression. 

PRINT PAGE
Register for email updates
Register now to receive our newsletter and updates on LCT’s activities and progress.